WALDENSTROM MACROGLOBULINEMIA
Clinical trials for WALDENSTROM MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTROM MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTROM MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill takes on tough blood cancers in early human trial
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called LP-168 in about 60 adults with several types of B-cell blood cancers (like lymphoma and leukemia) that have returned or not responded to prior treatments. The main goals are to find the safest dose and understand how t…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New drug SGR-1505 enters human testing for B-Cell cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called SGR-1505 in adults with various B-cell blood cancers (like lymphoma and leukemia). The main goals are to find the safest dose and understand side effects. About 98 participants will receive the drug, and researchers will monitor how …
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
Massive study seeks genetic clues to stop blood cancers before they start
Knowledge-focused Recruiting nowThis study aims to find genetic changes that cause early blood conditions to turn into cancer. Researchers will collect blood, bone marrow, or cheek swab samples from up to 10,000 people who have or are at risk for certain blood cancers. The goal is to better understand how these…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC
-
Spanish researchers launch national registry to unlock Waldenström's secrets
Knowledge-focused Recruiting nowThis study is creating a national registry of 1000 patients in Spain diagnosed with Waldenström macroglobulinemia or related conditions over the past 30 years. Researchers will review medical records to learn about symptoms, treatments, and long-term outcomes. The goal is to bett…
Matched conditions: WALDENSTROM MACROGLOBULINEMIA
Sponsor: Fundación Española de Hematología y Hemoterapía • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC